Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …

EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …

Nasopharyngeal carcinoma (NPC) is consistently associated with Epstein-Barr virus (EBV)
infection in regions in which it is endemic, including Southern China and Southeast Asia …

Orexin A (OXA) is a neuroprotective peptide that exerts protective effects on multiple
physiological and pathological processes. Activation of autophagy is linked to the …

Epstein–Barr virus (EBV) lytic induction therapy is an emerging virus-targeted therapeutic
approach that exploits the presence of EBV in tumor cells to confer specific killing effects …

Epstein–Barr virus (EBV) establishes a lifelong latent infection that can be a causal agent for
a diverse spectrum of cancers and autoimmune disease. A complex and dynamic viral …

Epstein-Barr virus (EBV) is strongly associated with a spectrum of EBV-associated
lymphoproliferative diseases (EBV-LPDs) ranging from post-transplant lymphoproliferative …

Epstein-Barr virus (EBV) is a ubiquitous human γ-herpesvirus that is causally associated
with various malignancies and autoimmune disease. Epstein-Barr Nuclear Antigen 1 …

Background Orexin-A (OXA) is a polypeptide produced in the hypothalamus, which binds to
specific receptors and exerts multiple physiological effects. Autophagy plays a vital role in …

We previously reported that the cellular transcription factor hypoxia-inducible factor 1α (HIF-
1α) binds a hypoxia response element (HRE) located within the promoter of Epstein-Barr …